Titan Pharmaceuticals
TTNP
#10418
Rank
HK$47.72 M
Marketcap
HK$35.88
Share price
-3.76%
Change (1 day)
27.13%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -HK$21.86 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$36.63 Million, an increase over its 2023 earnings that were of -HK$43.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$21.86 Million-40.33%
2024 -HK$36.63 Million-15.5%
2023 -HK$43.34 Million-45.43%
2022 -HK$79.43 Million16.29%
2021 -HK$68.3 Million-907.36%
2020 HK$8.45 M-106.6%
2019 -HK$0.13 Billion82.4%
2018 -HK$70.22 Million-36.93%
2017 -HK$0.12 Billion-378.62%
2016 HK$39.96 M-145.53%
2015 -HK$87.78 Million369.37%
2014 -HK$18.71 Million-125.9%
2013 HK$72.2 M-177.74%
2012 -HK$92.88 Million13.59%
2011 -HK$81.76 Million74.37%
2010 -HK$46.89 Million3.61%
2009 -HK$45.26 Million
2007 -HK$0.15 Billion12.08%
2006 -HK$0.13 Billion-28.65%
2005 -HK$0.18 Billion-10.03%
2004 -HK$0.2 Billion-6.08%
2003 -HK$0.22 Billion-14.76%
2002 -HK$0.25 Billion32.52%
2001 -HK$0.19 Billion27.55%
2000 -HK$0.15 Billion62.5%
1999 -HK$90.68 Million4.04%
1998 -HK$87.16 Million49.33%
1997 -HK$58.37 Million-27.88%
1996 -HK$80.94 Million13.04%
1995 -HK$71.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-HK$0.95 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$91.89 Million 320.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.10 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.77 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
HK$0.20 B-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA